(2S)-5-(4-((2-FLUOROBENZYL)OXY)PHENYL)PYRROLIDINE-2-CARBOXAMIDE, 90.0%, 250mg

2-Butanol, min. 98.5%, for synthesis, 500 ml, glass packaging

(6R)-3-[(2-chlorophenyl)sulfanyl]-6-[4-(morpholin-4-yl)phenyl]-6-(thiophen-3-yl)piperidine-2,4-dione, 98%, 1mg

(R)-3-((tert-Butoxycarbonyl)amino)-4-(3-fluorophenyl)butanoic acid, 95.0%, 100mg

Ethyl 2-(2-bromoimidazo[2,1-b][1,3,4]thiadiazol-6-yl)acetate, 95%, 50mg

(4-Formyl-2-methoxyphenoxy)acetic acid, 250mg

Ethyl 2-amino-4,5-bis(2-methoxyethoxy)benzoate hydrochloride, 95.0%, 5g

Z-Asp-OBzl, 95.0%, 500g

Diethyl heptanedioate, 95.0%, 100g

3-Chloro-2,4-difluorobenzyl alcohol, 250mg

2-CYCLOPROPYL-2,2-DIFLUOROACETIC ACID, 1g

2,6-BIS((DI-TERT-BUTYLPHOSPHINO)METHYL)PYRIDINE, 95%, 1g

2-Methylisothiazolidine 1,1-dioxide, 95.0%, 100mg